Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.

Bibliographic Details
Main Author:	PLOS ONE Editors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0240965

id	doaj-979091afb0584144a07a50cd3490176c
record_format	Article
spelling	doaj-979091afb0584144a07a50cd3490176c2021-03-03T22:03:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011510e024096510.1371/journal.pone.0240965Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.PLOS ONE Editorshttps://doi.org/10.1371/journal.pone.0240965
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	PLOS ONE Editors
spellingShingle	PLOS ONE Editors Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE
author_facet	PLOS ONE Editors
author_sort	PLOS ONE Editors
title	Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
title_short	Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
title_full	Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
title_fullStr	Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
title_full_unstemmed	Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
title_sort	expression of concern: vitamin d sufficiency, a serum 25-hydroxyvitamin d at least 30 ng/ml reduced risk for adverse clinical outcomes in patients with covid-19 infection.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2020-01-01
url	https://doi.org/10.1371/journal.pone.0240965
work_keys_str_mv	AT plosoneeditors expressionofconcernvitamindsufficiencyaserum25hydroxyvitamindatleast30ngmlreducedriskforadverseclinicaloutcomesinpatientswithcovid19infection
_version_	1714813696806486016

Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.

Similar Items